- Report
- January 2026
- 200 Pages
Global
From €4612EUR$4,995USD£3,896GBP
- Report
- March 2026
- 58 Pages
Global
From €9229EUR$9,995USD£7,795GBP
- Clinical Trials
- February 2026
- 1320 Pages
Global
From €3185EUR$3,450USD£2,691GBP
- Clinical Trials
- February 2026
- 780 Pages
Global
From €3185EUR$3,450USD£2,691GBP
- Clinical Trials
- January 2026
- 707 Pages
Global
From €3185EUR$3,450USD£2,691GBP
- Clinical Trials
- January 2026
- 149 Pages
Global
From €3185EUR$3,450USD£2,691GBP
- Clinical Trials
- November 2025
- 68 Pages
Global
From €3185EUR$3,450USD£2,691GBP
- Report
- February 2026
- 160 Pages
Global
From €3065EUR$3,320USD£2,589GBP
€3832EUR$4,150USD£3,237GBP
- Report
- August 2026
- 146 Pages
Global
From €3647EUR$3,950USD£3,081GBP
- Report
- January 2026
- 153 Pages
Global
From €3647EUR$3,950USD£3,081GBP
- Report
- February 2026
- 151 Pages
Global
From €3647EUR$3,950USD£3,081GBP
- Report
- February 2026
- 188 Pages
Global
From €4478EUR$4,850USD£3,783GBP
- Report
- November 2025
- 150 Pages
Global
From €4478EUR$4,850USD£3,783GBP
- Report
- March 2026
- 280 Pages
Global
From €4478EUR$4,850USD£3,783GBP
- Report
- February 2026
- 180 Pages
Global
From €4478EUR$4,850USD£3,783GBP
- Report
- February 2026
- 188 Pages
Global
From €4478EUR$4,850USD£3,783GBP
- Report
- February 2026
- 195 Pages
Global
From €4478EUR$4,850USD£3,783GBP
- Report
- February 2026
- 202 Pages
Global
From €4478EUR$4,850USD£3,783GBP
- Report
- February 2026
- 220 Pages
Global
From €4478EUR$4,850USD£3,783GBP
- Report
- December 2025
- 150 Pages
Global
From €4478EUR$4,850USD£3,783GBP

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more